News >

Treatment Strategies Expanding for Elderly Patients With CLL

Danielle Bucco
Published: Monday, Nov 27, 2017

Jacqueline Claudia Barrientos, MD

Jacqueline Claudia Barrientos, MD
Combinations with chemotherapy and immunotherapy have historically not been an attractive approach for elderly patients with chronic lymphocytic leukemia (CLL), due to the comorbidities these patients likely already have.

.

OncLive: Can you provide an overview of your presentation on the management of elderly patients with CLL?

Barrientos: The most important thing to understand is that elderly patients have many comorbidities that may affect their ability to tolerate a particularly therapy in CLL. By the time that these patients require therapy, most of them have at least 4 comorbidities, such as high blood pressure, cardiac disease, or are at high risk for kidney or liver disease.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology StrategiesJul 30, 20191.0
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Publication Bottom Border
Border Publication
x